The Maria Sklodowska-Curie National Research Institute of Oncology is a specialized research institute and hospital of the Polish Ministry of Health. Based in Warsaw, it also has regional branches in Gliwice and Kraków.

During the past decade, Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 66 clinical trials were completed, i.e. on average, 42% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 47 clinical trials were completed. i.e. 60.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy" #1 sponsor was "Merck Sharp & Dohme LLC" with 24 trials, followed by "Hoffmann-La Roche" with 23 trials sponsored, "Janssen Research & Development, LLC" with 19 trials sponsored, "Pfizer" with 12 trials sponsored and "Celgene" with 12 trials sponsored. Other sponsors include 118 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy" #1 collaborator was "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "Parexel" with 3 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy" are "Carcinoma, Non-Small-Cell Lung" (12 trials), "Crohn's Disease" (9 trials), "Multiple Myeloma" (8 trials), "Non-Small Cell Lung Cancer" (6 trials) and "Melanoma" (5 trials). Many other conditions were trialed in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy" in a lesser frequency.

Most popular intervention types in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy" are "Drug" (190 trials), "Biological" (33 trials), "Other" (16 trials), "Procedure" (6 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Pembrolizumab" (25 trials), "Carboplatin" (18 trials), "Cisplatin" (14 trials) and "Paclitaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy" are 186 trials for "All" genders, 14 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy". undefined are not yet recruiting, 55 are recruiting, 56 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 69 completed trials in Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, 24 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy has several departments that took part in Clinical trials: "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii" - 15 trials, "Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology" - 60 trials, "Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Klinika Gastroenterologii Onkologicznej" - 4 trials, "Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Ginekologii Onkologicznej ( Sit" - 4 trials